Baxter International Inc. (BAX)
NYSE: BAX · Real-Time Price · USD
24.42
+0.84 (3.56%)
At close: Sep 5, 2025, 4:00 PM
24.50
+0.08 (0.33%)
After-hours: Sep 5, 2025, 7:26 PM EDT
Baxter International Market Cap
Baxter International has a market cap or net worth of $12.54 billion as of September 5, 2025. Its market cap has decreased by -32.10% in one year.
Market Cap
12.54B
Enterprise Value
20.58B
1-Year Change
-32.10%
Ranking
Category
Stock Price
$24.42
Market Cap Chart
Since September 8, 2020, Baxter International's market cap has decreased from $41.54B to $12.54B, a decrease of -69.81%. That is a compound annual growth rate of -21.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 12.53B | -16.09% |
| Dec 31, 2024 | 14.93B | -23.83% |
| Dec 29, 2023 | 19.60B | -23.70% |
| Dec 30, 2022 | 25.69B | -40.50% |
| Dec 31, 2021 | 43.18B | 6.56% |
| Dec 31, 2020 | 40.52B | -2.45% |
| Sep 8, 2020 | 41.54B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.94B |
| Johnson & Johnson | 430.51B |
| AbbVie | 376.28B |
| UnitedHealth Group | 281.10B |
| AstraZeneca | 253.90B |
| Novo Nordisk | 249.80B |
| Novartis AG | 249.52B |
| Abbott Laboratories | 231.15B |